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ABSTRACT 
This paper applies insights from linguistics and discourse analysis to prescription drug brand Web sites, with special reference to the 
100 top-selling drugs. Such sites give the outward appearance of being a place to go for straightforward information about a specific 
brand. In reality, they present a confused mix of brand information, health information and hype, muddled organization, and poor 
indication of authority, creating an imbalance between benefit and risk content. In so doing, they breach the letter and spirit of the 
regulations governing direct-to-consumer advertising, which the FDA has by default applied to such Web sites but which were not 
designed for this special type of discourse. The many communicative difficulties proven to be caused by Web sites in general, in 
particular for the elderly and less literate, also pose ethical problems. A rethinking of the verbal and visual design of these drug sites 
is needed -- and new regulatory guidance, for which this paper offers recommendations. At stake is not just the quality of health 
information at brand drug sites but also their credibility.  
 
 
Introduction 
More American consumers have been visiting the Internet 
than their doctors to obtain information about their health, 
according to a study published in 2007.
1 Indeed, a Pew 
Internet report of 2009 found that even for a specific health 
or medical problem, 57% of US adults searched online for 
assistance. Use of the social media is a fast-growing part of 
this picture: the 2010 Prevention Magazine Annual Survey 
reported that 60% of online health information seekers had 
used social media.
2 Regarding online health-seeking by 
minorities, research is scanty, but Hispanics were found to 
favor Internet and broadcast advertising while Anglos 
preferred health Websites such as WebMD.
3 As for 
prescription and over-the-counter medications, 33% of US 
adults searched online for information about them in 2009, 
as against 19% in 2002.
4 
 
A Google search for information on almost any well-known 
prescription drug <x> during 2009 and the first half of 2010 
would have listed as first (non-sponsored) hit the company-
sponsored so-called 'official' brand site, <x>.com. Accurate 
figures or estimates for visits to <x>.com sites were not 
available to us at time of writing, but according to a 2005 
Accenture survey 22% of those surveyed sought facts on 
medications at brand Web sites,
5 and the 2010 Prevention 
Magazine Survey noted that 42% of respondents reported 
seeing an ad that connected to a site of this kind.
6  The fact 
that manufacturers were 'paying for placement'
7 suggests 
that they were generating considerable traffic, and a study 
found that brand sites were the most effective form of 
pharmaceutical marketing and were highly effective at 
generating new patient starts and refills.
8 At the same time, 
the Pharma industry appears to see the function of these 
sites as to 'both educate consumers and build relationships 
between brands and their target audiences', as one 
marketing agency executive has summarized it, but with the 
editorial content or other useful information serving to bring 
users back to visit the brand.
9  
 
This paper argues that 'official' brand sites pose serious 
communicative and ethical problems, which regulators have 
failed to address, and proposes a set of guidelines, using 
insights from linguistics and discourse analysis. 
 
The credibility that users have been attributing to Internet 
health information has been consistently high. According to a 
Pew Internet report of 2002, 72% of health-seekers said you 
can believe all or most online health information, and 69% 
said they had not seen any wrong or misleading health 
information on the Internet. At the same time, 47% of health 
seekers had rejected information from a site that appeared to 
be promoting a product or was just too commercial. A Pew 
report of 2006 records that three-quarters of American 
Internet health seekers said they checked source and date 
“only sometimes,” “hardly ever,” or “never”
10 , while some 
two thirds thought they could tell if a medical site is from a 
credible source prior to clicking on the search result 
according to a 2009 Manhattan Research report.
11 Compared 
to broadcasting and print, the Internet may now be perceived 
as a more credible source of prescription drug information
12, 
perhaps because it hosts substantial high quality content -- 
although few would list the Internet as more trusted than 
their physician.
13 ,
14 However, the recent rise of user-
generated social media has generated mixed judgments: the 
2010 Prevention Magazine Survey found that 58% of users 
regarded such sources of health information as trustworthy.
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A step toward greater credibility in on-line information for 
medications occurred on June 21, 2010, when, with no 
fanfare, Google introduced a policy ensuring that the first hit 
you would now be seeing (right after any sponsored x.com 
links) would be a link to a National Institutes of Health 
(National Library of Medicine) site with objective and more 
specific information such as “side effects.” The new feature 
was developed in partnership with NIH, who in turn license 
this data from The American Society of Health-System 
Pharmacists, which creates and maintains the data.
16,17,18  
 
In the early days of the Web, the FDA was inclined to regard 
on-line product information as labeling, and advised that “a 
good test for [firms seeking to utilize the Internet] would be 
to say, ‘Would I send the information I’m putting on the 
Internet out on hard copy?’”
19 However, following solicitation 
of opinion in 1998/9, the FDA postponed issuing guidelines in 
view of the uncertainty as to where the Internet was headed 
and how it would be used.
20, 21 At time of writing, the FDA still 
appears to view the situation as it was depicted by Marilyn 
Moberg and colleagues at that time:  “As a hybrid of print and 
electronic communication [and of labeling and advertising], 
Internet-provided information about a pharmaceutical or 
medical device on the Internet is likely to be subject to 
regulations that apply to either.”
22 Thus, five FDA untitled or 
warning letters relating to Web sites that were issued in 2005 
drew upon both broadcast and print advertising guidelines in 
faulting risk and efficacy information.
23 On 2 April 2009, the 
FDA issued 'untitled letters' to 14 of the world’s largest 
pharmaceutical companies for misleading “sponsored links", 
in which risk information failed to appear on every Web page 
that stated benefits.
24 The Pharma industry, uncertain how to 
handle this new medium, has lobbied for specific guidance.
25 
When the FDA did hold public hearings regarding the 
Internet, in November 2009, one of the five specific issues for 
which they sought opinions was: 'How can manufacturers, 
packers, or distributors fulfill regulatory  requirements (e.g., 
fair balance, disclosure of indication and risk  information, 
postmarketing submission requirements) in their Internet  
and social media promotion?'  However, discussions were 
almost wholly focused on the issue of promotion via third-
party social media tools.
26,27 
 
Our focus here is on prescription drug company-sponsored 
brand sites. A handful of studies have begun to explore them. 
Macias and Lewis
28 found that sites were using advertising 
appeals similar to those found in print ads, many with 
animated graphics, but with a great deal more medical and 
drug information.  They concluded that ‘consumers have 
more time to read and digest the information, the medium 
can better organize the quantity of information required for 
pharmaceutical drugs, and the Web may even be able to 
better teach consumers the technical aspects of drugs and 
the conditions they treat (as discussed in future research). 
Therefore, the Web is better able to meet the FDA 
requirement of "adequate provision" by "communicating all 
information relevant to the product's indication (including 
limitations to use) in consumer-friendly language".’  A follow-
up study
29 argued that a majority of direct to consumer brand 
sites were meeting the criteria of fair balance between 
benefit and risk information and adequate provision of such 
information, as well as several industry evaluative criteria.  
The value of a brand site during a product scare has also been 
recognized.
30 
 
In stark contrast, Huh and Cude
31 found that only one half of 
their sample of 60 sites provided risk information on the 
home page together with the benefit claims. (This has since 
improved, in response to FDA warning letters, with 'safety 
information' now standard on every page.) They further 
found that risks on 50% of the sites were couched in smaller 
font, and that one quarter of the sites lacked any navigational 
link to such information. Further doubts have now been 
raised by Sheehan
32, who points out that by the FTC’s ‘clear 
and conspicuous’ standards for disclosure
33, which require 
that risk be presented adjacent to benefit, only one third of 
the 91 sites she examined could be deemed to be in the spirit 
of fair balance. Sheehan further criticizes the frequent need 
to scroll down to risks, and more generally the multitude of 
formats making it so hard for the user to develop a mental 
schema for handling Web sites -- and comments that ‘FDA’s 
lack of guidelines for branded drug Web sites is clearly 
apparent in the range of formats and information provided at 
these Web sites.’ Vigilante & Wogalter
34 additionally found 
that risk and benefit information are located faster, and were 
much preferred, when set in separate sections, at the top of 
the home page. 
 
Macias and Lewis’s upbeat conclusions, mentioned above, 
also jar with findings about the poor usability of consumer-
oriented brand name Web sites in general. An analysis
35 
published in 2007 of 500 company sites revealed that three 
features that might be adjudged critical to risk/benefit 
balance were in short supply: Just 10% used a breadcrumb 
trail showing the path back to the home page, 23% had a site 
search capacity, and just 14% offered a FAQ or Help option.  
 
Meanwhile, Internet communication analysts have 
recognized that as a communications and marketing medium 
it is quite different from other forms of communication on 
several dimensions, e.g. interactivity, control, dynamic 
content, and depth of content. For example, online branding 
may have more to do with the interactive experience lived in 
front of the screen than with texts or icons it contains.
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The conceptual structure of Web sites and the establishment 
of best practices have been a particular concern
37,38,39 and a 
wide range of problematic communicative features have 
been identified:
40,41,42,43,44 
 
(a) Web sites have no obvious 'next page' or closure, nor even 
a clear starting point on their home page. Instead, they are 
'hypermodal'
45, i.e. constructed around an unordered series 
of links. One is thus constantly compelled to make navigation 
choices, as in a kind of maze. Average page view time has 
been put at 10-12 seconds.
46 Navigability has been cited by 
Internet users over 50 as their top problem. Site maps would 
help, or good old-fashioned tables of contents (a great virtue 
of Wikipedia), but they are not easily to be found. 
(b) The overall significance or thrust of a Web site is hard to 
judge. There is no natural place for a summary or parting 
message or tagline.  
(c)  The individual Web page itself lends itself to modularity 
and discontinuity, to a reading process not based on an 
anticipated trajectory, and to a different logic of 
argumentation such as 'Web rings'.
47,48,49 
(d) Content is liable to change or vanish from one visit to the 
next, with little indication of when a page or site was last 
updated.  
(e) Text on a computer screen is hard to read. Indeed, there is 
evidence that high-literate users generally scan rather than 
read such text, commonly in an F-pattern, i.e. plowing the 
upper content bloc (typically the first two paragraphs), then a 
shorter bloc below it, and then scanning down the left side of 
the page. They read no more than 20-25% of the text on a 
visit to a page.
50,51,52 
(f) One consequence of such F-pattern scanning is that on link 
labels the first two or three words are commonly all that gets 
noticed, often adding to navigational problems.
53 
(g) Printing out the site is no easy solution but a long and 
tedious operation. 
(h) Site search engines, the best alternative resort, are often 
problematic, owing to the issue of hyphens, plurals and the 
like, as well as varying forms of prioritization.
54 
 
Consistency in Web design has been identified as one of the 
most critical principles of Web page usability. In the words of 
Jakob Nielsen, 'The more users' expectations prove right, the 
more they will feel in control of the system and the more 
they will like it.'
55 When an Internet user is on a high-
involvement information search, these expectations are 
heightened.
56 
 
All of this is particularly hard on seniors, the less literate, and 
on others who find reading a challenge. Seniors had a 53% 
success rate at four fact-based Web tasks compared with 78% 
for a control group aged 21-55, took overall 70% longer, and 
voiced strong preference for the high-usability sites.
57 
Eyesight, memory and precision of movement pose further 
problems. The less literate (defined as below 9th grade 
reading level) were estimated in 2005 as comprising 30% of 
Web users, projected to rise to 40% by 2010.
58 They are 
thought to view Web sites quite differently: rather than scan 
to identify key information, they read word for word, scrolling 
disorients them, as do busy Web pages and graphics; spelling 
search terms is a problem.
59,60 In a Pfizer-funded study, a less-
literate group had a 46% success rate (vs. 68% for a higher-
literacy group) at seven fact-based Web tasks at a major 
Pharma product site, designed by a respected agency; but 
this rose to a 82% success rate when the site was simplified, 
e.g. by placing chief information at the top and listing main 
choices in a linear menu. 
 
Legibility problems are not confined to seniors. Tiny fonts 
were nominated as by far the worst design mistake of 2005 
by readers of the Jakob Nielsen newsletter, followed by link 
navigation issues.
61 
 
This is not to suggest that there is a health-seeking Babel, or 
that cyberquackery and cyberchondria reign supreme, as the 
medical journals sometimes imply. For one thing, search 
engines are structuring certain online information in ways 
which evoke the 'traditional' media, giving the spotlight to 
governmental, biomedical and charitable interests,
62 and now 
also to a lot of quality content from Wikipedia,
63 although 
much searching does require sifting through piles of poor-
quality sites.
64 Users have shown some skill at identifying 
quality sites.
65 As the digital media penetrate every corner of 
society, qualitative studies reveal that weaker groups have 
been acquiring some basic techniques and comfort level in 
their online 'health habitus'.
66,67 However, all is clearly not 
well. A research review published in 2004 reported that 
people seldom went beyond the first page of a search, had 
limited search and evaluation skills, and often paid no 
attention to credibility cues.
68 
 
Two further problems, by no means inherent to the Web but 
endemic to commercial Web sites, are 'stickiness'
69 -- the use 
of multiple strategies to detain a visitor -- and ‘patchworking’, 
the general tendency of designers to patch together materials 
from quite disparate sources to make up a page. Thus, for 
example, a Learn About Allergies page mixed a voice-over 
style ('If you're looking... you've come to the right place') with 
statistics and long paragraphs. Or, arriving at an FAQ page, 
one may have the distinct feeling that the "answers" were 
written by some pundit and the questions added as an 
afterthought.    
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With all these communicative handicaps, the consumer is ill-
equipped to deal with what we are going to suggest is the 
most striking characteristic of brand drug sites: the fuzzy mix 
of promotion and information.  
 
It is remarkable that no attempt has been made by the FDA 
or Industry to draw up specific guidance for brand Web sites, 
which today perform a function parallel to and in many ways 
superior to the other media used in direct-to-consumer 
advertising, both print and broadcast -- especially in terms of 
their capacity and ease of access.  
 
FDA guidance for direct-to-consumer drug promotion in 
broadcasting and print ('promotion' and 'advertising' are used 
interchangeably by the FDA, although some would distinguish 
the two
70) has had a lot to say about the definition of ‘false 
and misleading’ and the doctrine of ‘fair balance between 
information about effectiveness and information about 
risk’
71,72 Essentially, balancing information has to appear in 
the primary text of the promotional material, in consumer-
friendly language. As practice has evolved, the FDA has 
revisited the issue, primarily in the ongoing but diffuse form 
of warning letters, e.g. faulting 'minimization of risk' where 
efficacy claims were 'presented using large, bolded headers 
and with significant amount of white space around them' 
while risk information was 'presented in the bottom half of 
the ad in difficult to read font and typography'
73 (gist of 
warning letter for Prograf, 8/31/06); so too, occasionally, 
have the courts.
74 Meanwhile, clinicians and researchers have 
voiced persistent alarm, mitigated only by evidence that 
advertising promotes greater health awareness.
75  
 
However, in practice, scant attention has been paid by the 
FDA to some equally crucial aspects of ‘fair balance’ and ‘false 
and misleading’: the part played by the reader/listener, and 
the nature of the genre and the medium itself. The belated 
2009 draft guidance
76 opined that 'FDA looks not just at 
specific risk-related statements, but at the net impression', 
that 'simply [...] devoting the same amount of time or space 
to risk and benefit information will not necessarily make a 
promotional piece accurate and non-misleading' and -- 
distancing itself from ubiquitous TV and radio practices -- that 
'accompanying discordant visuals and distracting music' 
contravene fair balance. The FDA's ensuing Proposed Rule 
(March 2010) for information to be conveyed in a 'clear, 
conspicuous, and neutral manner' made clear that 'Nothing 
contrary to, inconsistent with, or in mitigation of, the 
required disclosures shall be used in any advertisement in any 
medium; nor shall any audio, video, or print technique be 
used that is likely to detract significantly from the 
communication of the disclosures.'
77 
 
To appreciate these issues requires some knowledge of 
discourse analysis, an approach that asks how the various 
elements in a text combine to send a message or a mixed 
message -- and the central role of context.   What, for 
example, if the quantity of risk and efficacy information is the 
same but the latter is more accessible or more appealing than 
the former? Or what if a media company employs 
‘postmodern’ text which tests the limits of what is literal or 
appropriate?
78,79, 80  But most important, for the present 
topic, is this:  What if health information is merged with 
product hype? And, more fundamentally, what is the nature 
of an Internet site, how do users relate to it, and how is the 
information there processed? 
 
Objective 
In this paper we wish to use insights from linguistics and 
discourse analysis to suggest that prescription drug brand 
Web sites give the outward appearance of being a place to go 
for straightforward information about a specific brand -- but 
that, in reality, they present a confused mix of brand 
information, health information and hype and hence, 
effectively, an imbalance between benefit and risk content. In 
so doing, they breach the letter and spirit of the regulations 
governing direct-to-consumer advertising. Taken together 
with the discourse properties of these sites and the many 
communicative problems shown to be posed by Web sites in 
general, in particular for the elderly and less literate, they 
necessitate a rethinking of the verbal-visual design of these 
drug sites -- and new guidance. At stake is not just the quality 
of health information at brand drug sites but also their 
credibility.  
 
Method 
Recent years have seen great advances in the understanding 
of the variables of communication and its context -- in 
particular, how language reflects and affects its social context 
and how composite texts (such as newspapers and 
advertisements) are organized.  
 
How and by what means a communication is interpreted is a 
matter of extraordinary complexity, variability and often even 
ambivalence. Interpretation depends, inter alia, on text, 
content, situation and communicative goals.  
 
Text is known to correlate with independent variables in the 
situation and the sender's goals. One influential model has 
tentatively proposed the following major situational 
variables: content of message, setting, participants, tone, 
mode (e.g. oral, written), norms of interaction (e.g. 
conversational etiquette), norms of interpretation, genre (e.g. 
poetry, prose, myth, report), and the actions and interactions 
taking place.
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genre, are in turn dependent to some degree on what is 
being said. 
 
Three major communicative goals may be identified: 
presentation (describing, requesting and so on), orientation 
(expressing an attitude to the message, the addressees and 
so on), and organization of the message.
82  
 
Such study of texts, spoken or written, thus involves going 
beyond the study of linguistic structures (so-called 'core 
linguistics') to embrace broader features of communication. 
In this paper, we wish to draw on two broad communications 
approaches, discourse analysis,
83,84 and ethnography of 
language,
85 as well as on linguistic observation per se. 
 
Discourse analysis examines the holistic interplay between 
text and context. For instance, the sentence 'Don't let 
seasonal allergies cloud your day' will not convey the same 
message or be equally appropriate in the context of a 
commercial voice-over, a magazine feature or header, a 
casual conversation, or a formal warning. The surrounding 
text and image can affect interpretation; so too can the 
participants' knowledge and the assumptions they bring to 
bear, their social and personal relationship and even their 
mood. What all these factors are and how they interact in, 
say, a magazine or a lecture is still far from fully understood. 
One focus has been 'multimodal' communication,
86 
combining such modes as oral and written text, still and 
moving image. Web page technology routinely offers a 
combination of all four modes.  
 
A pertinent accessory to discourse analysis is pragmatics, 
which theorizes how meanings are arrived at in practice and 
pays special attention to inferencing and connotations. Thus, 
the sentence 'You may be ready to switch to <medication>' 
can be a lot more than a descriptive statement. As used in a 
promotional context, it may amount to an encouragement, in 
much the same way as can 'you may wish to [...]' in 
consultative and advisory contexts. Indeed, the phrase 'ready 
to do x' sometimes strongly suggests that x is desirable.  
 
Ethnography of language asks what different types of text are 
seeking to do and are perceived as doing -- and how this is 
reflected in language, format etc. What are termed 
'advertisements' and ‘technical information’ in our culture 
are two recognizable types of text or genre.
87 Other genres 
are press reports, recommendations, interrogations, and love 
letters. At the same time, a culture also classifies activities by 
the situation, institution, social group and so on (as against 
the form of the text); examples of 'activity types' are the job 
interview, the committee meeting, advertising, lecturing -- 
and this extends to 'virtual situations' such as the 
provision/doing of written interviews, the provision/reading 
of information leaflets and so on.  The discourse of parents 
and children, the elderly, the legal system and medical 
encounters has attracted considerable attention. Specific 
activity types often go together with genres and styles: there 
is a typical lecture style and a typical promotionalese. In a 
consult, a patient is typically asked 'How have you been' and 
responds with details of his or her health (rather than 
replying, 'And how are you?') 
 
However, we frequently nuance and even mask our behavior 
by borrowing stylistic features from one activity into another. 
For example, the physician will often preface the consult with 
a 'How are you' that belongs to the realm of socializing.  
 
Discourse analysis and ethnography of language focus on the 
text, the framing texts, and the context. While they can offer 
important pointers to how a text will be interpreted and even 
contested and to cognitive questions of how a text was 
intended, they make no predictions. Rather, they can 
complement empirical research, suggesting hypotheses and 
theoretical explanations. They are also important tools for 
social criticism and social policy making.  
 
Both approaches favor a qualitative methodology, largely 
based on analyst interpretation, owing to the complexities of 
messages and contexts, although quantitative studies are also 
sometimes feasible. 
 
Our data are drawn from an ongoing qualitative and 
quantitative discourse analysis that we are carrying out on 
the brand drug sites for the 100 top-selling prescription drugs 
of 2007-2009 and in part from our unpublished analyses for 
the years 2001-2006. The list of drugs is available by a Google 
search for 'Pharmacy Times top 200'. Our goal is to illustrate 
what this kind of qualitative analysis can offer, as well as to 
provide some analysis and conclusions. 
 
Results and Discussion  
Let us consider some common features identified by our 
analysis, with special regard for how promotion and 
education act and interact. 
 
1. Metadiscourse (texts about texts) 
Metadiscourse (texts about texts) helps create a frame that 
sets up user expectations and even interpretations. 
 
a. Names for genres in lay language 
In popular parlance, brand Web sites appear to be classed 
simply as 'Web sites'; our experience suggests that they are 
not called by any 'genre label' commonly used for non-
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'articles', 'newsletters', nor anything else that might help one 
identify them as promotional or informational. We found 
some support for these impressions when we examined the 
link titles and two-line page descriptions listed in search 
results for the 'official' sites of the 100 top-selling prescription 
drugs of 2009. The only terms that we could find there were 
the generic 'site' or 'official site'. Industry does not appear to 
use or promote any other nomenclature.
88 
 
b. Link titles and page descriptions: promise and reality 
We now turn to the Web sites themselves -- and to how they 
are individually 'packaged'. To a discourse analyst, jackets of 
books, titles of papers or poems, and -- in this case -- the link 
titles and page descriptions listed in search results are of 
considerable significance. Users and analysts tend to see 
them as encapsulating something defining about the work 
(although in reality aesthetic and other factors may play a 
part), which in turn may serve to frame the work for the user. 
Web site descriptions are likely to influence decisions about 
whether to enter a site.  
 
For each search result, Google, Yahoo and Bing return a link 
with a short 'title', created by the site designer; this title also 
appears as the page header at the home page.  Beneath this 
link is a one or two line 'page description' for the home page, 
automatically generated from the page to be most relevant 
to the user's query -- and beneath that, the Web site URL. 
 
First, compare three drug site descriptions provided by a 
Google search in June 2010.  (The ellipses are in the text.)
89 
 
  Aranesp®(darbepoetin alfa)  Manufacturer provides 
indications, side effects, contraindications and 
mechanisms of action of this treatment for anemia 
associated with chronic renal... 
  PLAVIX® (clopidogrel bisulfate): Help prevent Clot 
formation for ...  PLAVIX, proven to help protect against 
future heart attack or stroke. Click for safety and Full 
Prescribing Information Including Boxed Warning. 
  VALTREX and Genital Herpes Information – Valtrex.com  
Genital herpes information from VALTREX, the once-daily 
herpes medication that may be right for you. 
 
The Aranesp description sounded strictly informative, but the 
descriptions for Plavix and Valtrex contained a promotional 
element ('proven to', 'once-daily... may be right for you'). A 
promotional element also figured in the Plavix 'title' ('Help 
prevent...').  
 
The data lent themselves to a quantitative analysis of the 
Google links and page descriptions for the 'official' sites of the 
100 top-selling prescription drugs of 2009 in terms of theme 
and goal. This yielded three categories: (1) condition and 
product information, (2) product information, or (3) product 
information and promotion. Promotion was defined as 
involving comparisons such as 'the only...', 'a different kind of 
type 2 diabetes medication', appeals such as efficacy 
('powerful night and day relief'', 'with the power of 3 HIV 
meds in one pill daily') and ease of use ('easy-to-use'), and 
general encouragement to learn about the product ('Find out 
what you can do to manage high blood pressure'). 
 
The results (n=92) were: 
(1) condition and product information 10% 
(2) product information 54% 
(3) product information and promotion 36% 
 
Meanwhile, running beneath each page description, the URL 
<brand name>.com indicated that the sites were brand-
oriented but users were entitled not to infer from this that 
they were promotional or at least not exclusively so. Thus, 
only a minority of the Web sites signaled that they were 
promotional. The majority give the appearance of being a 
place to go for straightforward information about a specific 
brand. 
   
In reality, we found that page descriptions and link titles were 
frequently misleading in this respect. Here are two examples: 
A page at singulair.com entitled What Exactly Is Asthma? 
displayed a prominent For more information with two links, 
one to Parent Of An Asthma Sufferer and the other to I am an 
Asthma Sufferer -- but both were promoting the product. 
Similarly, clicking on the Google search link to Valtrex.com, 
which promised a page of genital herpes information, 
brought us to a page promoting Valtrex.  
 
To combine promotional and consumer education per se is 
not peculiar to drug promotion. Discourse analysis of 
advertising and consumer education has established that 
each likes to borrow 'tricks' out of the other's book, in part 
because the two share some overlapping goals. Advertising, 
indeed, is commonly attached to or embedded in other texts, 
tending to draw on their authority. The best ads have been 
likened to 'bandits, raiding the accompanying discourse but 
with the sense not to stay too long.' Ultimately, advertising is 
as inventive as literature.
90 Ethical criticism of the more 
hybrid sorts of advertising has highlighted such genres as 
newspaper consumer supplements, with their mix of 
objective and flattering tones and their ads and links 
suggestive of endorsements.
91  Advertising campaigns for 
non-medical products such as detergents have long cultivated 
'scientific' discourse, and the same strategy is being used with 
quasi-medical products such as functional foods.
92   
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However, the name and frame of the text will commonly 
make it possible to categorize it as either promotional with 
some informational content (which many will interpret with 
due caution) or as informational with some promotional 
content. Examples of the former are product brochures and 
infomercials.
93,94 An interesting example of the latter are 
newspapers: Some newspapers have overwhelmingly 
advertising content, but their title (e.g. Daily Tribune), the 
type of news they carry, and popular reference to them as  
'newspapers' will probably signal that the editorial and news 
content is to treated as non-promotional.  
 
Where, then, a user comes to a Web site for information and 
finds it mixed with promotion, the lack of a clear mental 
schema may increase confusion. A socialized skepticism for 
ads will often further reinforce this. 
 
2. Organization of menu and page content 
Less egregious but particularly widespread was the practice 
of jumbling health and product links within the same menu. 
Thus, on the home page of purplepill.com, a vertical bar 
menu listed six items, the first and last of them product links 
and the intervening four health links; meanwhile, in a 
horizontal row of anchor links, the left two were strongly 
promotional while the rightmost was a health link. Our data 
for the same 100 top-selling drugs sites found that only 18% 
of sites kept condition/ailment information distinct from 
brand information or promotion.  
 
The discourse analyst will wish to assess such mingling 
against general mingling of advisory and promotional 
discourse in American culture, in specific genres and specific 
realms. Supermarket consumer newsletters, for instance, 
may be able to tolerate a specific amount or type of 
advertising.     
 
In general, muddled navigation and organization of content 
was found to be common. Thus, arriving at a page, we often 
found that the material was a word-for-word copy of another 
page, or, maybe worse, just slightly different. The following 
was typical: A page entitled Consumer Information offered 
two links, ostensibly, to a disease-specific and a product-
specific page. However, we found not one but three product 
pages, for there was a third link, bewilderingly entitled 
Product Information -- and a fourth link, entitled Your Guide 
to xxx Tablets. The third and fourth pages, in fact, were 
almost carbon copies, but just different enough to suggest 
that two editors created them without conferring with one 
another.  
 
It is hardly surprising if Internet users have been found to 
drift about, not paying attention to names of links or precise 
wording of texts, often not finding what they want or 
knowing how to get back to where they started. There are 
usability and credibility issues here, quite apart from any 
ethical or regulatory considerations. When the consumer 
comes looking for information and finds repeatedly -- as our 
data indicate -- that home pages are strongly promotional, 
there is evidence that it compromises the credibility of 
informational content elsewhere on the site. Two factors are 
at work here: (a) Information seekers usually skip 'in-your-
face' advertising using banners, animations and the like;
95 (b) 
Internet users in general give less credence to pages that are 
muddled in form or function.
96, 97 
 
3. The dominance of promotional imagery 
Promotional imagery has come to dominate drug ads for TV 
and print ads -- despite regulators' frequent caveats about 
distraction effects --and now similarly for brand drug sites. 
Most sites in a study of 113 of the top 200 drugs of 2004 used 
female models bubbling with health.
98  
 
If the home page prominently displays a image that is 
promotional (i.e. suggestive of well-being, quirky, highlighting 
a free trial, providing a video testimonial, or the like), it is 
probable that the user will categorize the home page and 
possibly the entire site as an advertisement -- particularly in 
the absence of any framing that suggests otherwise. 
Analyzing home pages at the 'official' sites of the 100 top-
selling prescription drugs of 2009, we found that 68% 
displayed a prominent promotional image. For most 
companies, then, but by no means all, the official Web site 
was an extension of their advertising campaign.  
 
At several sites, the home page was dominated by the 
promotional image, with Safety Information tucked away 
'beneath the fold'. At one home page, a tiny 'Individual 
results may vary' was almost lost against a large promotional 
image.  
 
This raises several issues. First, do information seekers resist 
promotional images uniformly, as they have been shown to 
do with online banner ads and the like, or is there a tolerance 
for the soft-sell imagery so commonly used -- such as the 
inviting track through the meadow under the slogan 'A 
medicine to help you move forward' at abilify.com?  Second, 
given the proven difficulties with scanning a Web page, how 
easily do information seekers skirt this promotional matter? 
Third, to what extent do designers even separate 
informational content from promotional areas? At that same 
abilify.com home page, we found that all the menus for 
informational content were located within the promotional 
image and in the same style and color -- a clear if subtle 
attempt to inject brand promotion into help seeking. Even Original Research  POLICY 
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more subtle, and widespread, is the use of a brand design 
(using color, font and images without borders) for the entire 
home page or even an entire site, as we found at 
purplepill.com, akin perhaps to a brand theme tune running 
through an ad. Paradoxically, FDA Draft Guidance (2009) 
warned that 'problems can arise when parts of a print 
promotional piece appear so unrelated that the risks do not 
look to be part of the piece' (e.g. 'Risk information is placed in 
a thin column along the side of an ad in a different font and 
color scheme.')
99 However, the Guidance fails to address 
what may be a much more frequent phenomenon of print 
information (risks or benefits) embedded in promotional 
hype. 
 
A further issue of concern is the popularity of 'postmodern' 
promotional imagery, using ironies, paradoxes, puns and 
ambivalences. As imagery is usually interpreted through text, 
there is a risk that postmodern text can subvert trust in 
informational content, particularly where this is embedded in 
a brand design. Whatever may be known about the 
interactions between promotional and informational content 
in print, the nature of communication and usability on the 
Web may produce quite different interactions. 
 
4. Who is the 'sender'? 
At 75% of the 100 top-selling sites we examined, a page with 
ostensibly objective but anonymous expert advice was 
flanked by a prominent product pitch (such as a free offer, a 
testimonial or a 'how <medication> may help', the latter very 
often part of a site template. Thus, a piece beginning 'Your 
doctor can help you reach your cholesterol and heart-health 
goals' was set alongside a prominent 'Get money-saving 
offers and save on LIPITOR'. 
 
Discourse analysis is concerned with who is (and who appears 
to be) doing the talking, to whom, and on behalf of whom -- 
or, to use the technical term, what is the "footing" of the 
text?
100 A distinction may have to be made between the 
animator (the end 'speaker'), the scriptwriter, and the 
'principal' (the responsible party). Who then is, or is 
represented as, the voice of these drug sites? Behind the 
nameless copywriters and media agencies, users are allowed 
to hear the company (via its discrete logo and its brand) -- but 
who else? The medical profession?  The FDA? Satisfied 
customers?  Is the brand itself projected as a person, e.g. by 
deployment of anthropomorphic images? In the cases we 
examined, the company seemed to portray itself as animator 
and principle for the entire site, including the health 
information. In the absence of named authors or institutions 
to vouch for the health information, how users assess the 
voice behind this information may depend in part on the 
overall footing of the page and on background knowledge 
about such web sites and the Pharma Industry.  
 
Similarly, is the implied addressee a patient thinking of 
seeing, or already seeing, a doctor about the condition? 
(Recall the ubiquitous  'Ask your doctor about...') patients' 
families? Or a broader public that needs educating? In actual 
fact, the implied addressee for a TV ad -- a broad class of 
viewer, exposed to this ad as passive spectators -- may be 
rather different from the implied reader of a product site, 
who presumably went looking for the site in the first place. 
 
Consumers have told researchers that they care intensely 
who is behind pharmaceutical and medical help sites -- 
fearing who lurks on the Web.
101, 102, 103 And of commercial 
sites in general, the 2002 Princeton Survey of Web users 
found that only 29% of lay users said they trusted them.
104 A 
small observation study found that those same participants 
who claimed to check sources, disclaimers and the like did no 
such thing, while few participants even recalled
 which 
Websites they had used.
105   One wonders how many health 
information seekers are, in fact, thinking that all these 
'official' drug sites have been passed by the FDA. Precisely 
this was found to be the belief about TV drug ads.
106 In any 
event, one study of brand drug Web sites reports that 
indication of professional authority, such as authorship and 
academic sources, was relatively scarce
107 -- in sharp contrast 
with the vague 'research shows, experts suggest' language 
that food supplement sites are freely allowed to deploy.
108 
 
 
5. Relationship to the receiver and the content 
Besides its content, a text often expresses the sender's 
relationship to the receiver and the text.  In this respect, 
promotional style differs sharply in tone from informational 
or educational style.
109 Two common features of 
'promotionalese' are the use of 'invitational' imperative verbs 
and a relationship-building 'you, yours', as in this message at 
one home page: 'Get ready to learn more here on our Allegra 
Web site and discover the allergy relief you've been looking 
for.' A study of probiotic yogurt sites has highlighted a similar 
use of the imperative and the pronoun 'you' as relationship 
builders.
110  
 
In fact, expression of relationship involves several variables. 
For example, a linguist will consider: 
Social distance:  intimate, formal, distant?  
Social power: forceful, diffident?  
Degree of seriousness: sober, light, factually loose, ironic?  
 
Degree of seriousness involves a relationship to the text as 
well as to the receiver, in particular a variable of factuality:  Original Research  POLICY 
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How factual is the sender about the message, or how factual 
does he/she wish to appear? 
 
Regarding seriousness and factuality, direct-to-consumer 
drug advertising raises a difficult issue: How accurate must all 
the content be? The mission of the FDA's Division of Drug 
Marketing, Advertising and Communication unequivocally 
requires prescription drug information to be 'truthful, 
balanced, and accurately communicated',
111 but nonetheless 
a culture of promotional hype -- often suggesting (but never 
asserting) that the drug cures you and makes you happy or 
that the drug is better than its competitors or that you would 
be socially desirable for taking it -- has been allowed in 
broadcast and print advertising (although it has sometimes 
stirred the FDA to express concern). In the explicit statements 
about the medication, everything may be truthful and 
accurate, but in the implicit claims about the outcome of the 
treatment or the desirability of the medication, all is not true 
or subject to validation.  
 
To take three instances of suggestive claims in our data: 
Remicade used an effectiveness and happiness message that 
it 'has been used to treat more than one million people 
worldwide across all uses', accompanied by a cool, smiling 
male in dark glasses. A verbal social desirability appeal was 
the 'Angela was born to be wild' campaign on Lantus.com, 
depicting a biker under the slogan 'Her power'. Or again, the 
message 'You may be ready to add or switch to <medication>' 
is subtly suggesting that this medication is better and that 
one just needs to wait for the circumstances to be right.  
Consumers have been assumed by regulators to be capable of 
shrugging off the hype they hear in this 'caveat auditor' zone. 
However, from the outset there has been a different 
regulatory convention for labeling and print promotion: Any 
promotional labeling has to be accompanied by a detailed 
and technical patient leaflet while print ads require the 
equivalent on an adjoining page -- all of this with zero hype.  
 
6. Degree of coherence or dissonance in style and format: 
Copywriters' attempts to inject a sober and informative 
element amid the promotion sometimes produced stylistic 
dissonances. Consider this, from an 'All About' page: 'Learn 
how once-a-day Allegra works to manage your seasonal 
allergy symptoms and how it works best when taken as 
directed by your physician.' What sounds normal as a sign-off 
to a commercial voice-over sounds quite bizarre here as 
written text in an educative context. In the same way, the 
attempt to pack disparate content and formatting into a 
single page creates a sharper dissonance on a Web page than 
in print, owing to the cognitive problems of Web page 
processing referred to earlier. The presence of large blocks of 
safety information on the same screen as an attractive image 
is a case in point.  
 
Coherence in language and formatting has more than just 
cognitive value. Not only can it serve, in our case, to 
distinguish education from promotion but it can also have a 
symbolic value, by signaling to consumers that the material 
was coherently thought out and that they can trust that 
education. This may be acutely felt where readers are 
unwilling to take such coherence for granted.    
 
Conclusion 
With its mix of written, oral and visual modalities, its maze of 
navigational choices,  its atomized viewing giving little sense 
of the whole, and its many other cognitive peculiarities, 
Internet analysts have consistently warned that the Web 
poses severe difficulties for all users, the elderly and less 
literate in particular. A large proportion of users have no clear 
gestalt or iterative schema to tell them what to make of a 
web site, nor even an opportunity for interacting with other 
users and coming to a shared meaning.
112  
 
Amid this communicative tangle, brand drug sites appear to 
pose a particular communicative problem. Whereas print and 
broadcast ads are clearly seen as 'advertising', function as 
such, and are regulated as such, brand drug sites have been 
designed to function simultaneously as advertising and as a 
repository of technical and consumer information. Both 
companies and regulators have welcomed the opportunity to 
provide the kind of product information that the Law requires 
but which cannot possibly be packed into a 30 second spot. 
However, our communicative analysis of these sites has 
identified a hybrid of advertising and information which 
existing regulations were not designed to address -- and 
which is not meeting consumers' needs for adequate and 
balanced information. This confirms the assessment 
regarding the findings of the Prevention Magazine 2010 
Direct-to-Consumer Advertising Survey with respect to online 
drug advertising, voiced by Cary Silvers, Director of Consumer 
Insights for the publisher: "Consumers are more responsive 
to the 'fair balance' in traditional media due to its familiarity 
and the recognizable formula. In magazine and TV ads, risk 
has appeared in a very consistent manner, mainly the black 
and white page and the voice-over. New and evolving online 
formats have not delivered the same level of recognition thus 
far." 
113 
 
In this paper I have illustrated two methods of 
communicative analysis -- discourse analysis, the study of 
texts and their interaction with image and context, and 
ethnography of language, the study of language as action -- 
which we have been employing to analyze brand prescription Original Research  POLICY 
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drug sites, with particular reference to the 'official' sites of 
the 100 top-selling prescription drugs of 2009.   
 
These methods have recognized that in our culture, 
advertising and consumer information (or advice) count as 
distinct types of activity and that each has its own range of 
linguistic styles, genres, factuality and so on -- amounting to 
two distinct types of discourse. This distinction involves a lot 
more than the words themselves. Discourse types arise out of 
a complex of factors , such as verbal-visual interaction, style, 
situation, and speakers' own perceptions and expectations. In 
the case of advertising and consumer information there can 
be considerable overlap, with each borrowing the other's 
'tricks' and advertising seeking to morph and masquerade. 
Nonetheless, a reader or viewer will generally have adequate 
clues for categorizing the whole as 'essentially' advertising or 
information, and for evaluating it all accordingly.  
 
This, however, does not appear to hold true for brand drug 
sites, in view of the qualitative and quantitative findings that 
we have described for six types of discourse feature. 
Summing up these findings and some of their possible 
implications: 
 
1.  In lay nomenclature and search result listings, the sites 
are classed neither as promotional or informational. In 
the listings, a majority of the link titles and page 
descriptions signaled that the site or page contained 
product information rather than promotion, but the 
reality was frequently otherwise.   
2.  A large majority of the sites jumbled health and product 
links within the same menu. More generally, muddled 
navigation options and organization of content was 
widespread. 
3.  Most of the sites prominently displayed promotional 
imagery, which may create a suggestion that the site is 
promotional and that informational content embedded 
in it is less than objective. Another common feature of 
textual-visual interaction was brand templating of entire 
pages. 
4.  Expert content was delivered without a source and 
flanked by a prominent product pitch at most of the 
sites. Embedding in a brand template was common. 
Thus, the company seemed to portray itself as the voice 
behind the entire site, including the health information. 
5.  Sites sometimes sought to create a relationship with the 
addressee, using a promotional grammatical style. They 
also frequently played loosely with the facts of the 
product's benefits, by way of suggestive promotional 
hype. 
6.  The mingling or juxtaposition of educative and 
promotional style or format sometimes produced a 
dissonance, which may impede trust in the message.  
 
Companies have used their legal leeway to mix information 
and promotion at many levels: At the level of image and text, 
at the organizational level of links and pages, in style, in tone 
(hype and sobriety), and in an ambivalence of authorship and 
addressee.  
   
The FDA has insisted that the Web, being written matter, 
should be subject to all the constraints of magazines and 
labeling.
114 However, it is by now clear that the hype of drug 
promotion has migrated to the Web; and there, far from 
being fenced off as with labeling or print ads, it mingles in an 
unstable and unpredictable manner with serious content 
such as risk and safety information. Combining with the 
intrinsic cognitive difficulties of the Web, this kind of 
discourse may be jeopardizing the effectiveness of risk 
information and undermining the credibility of the whole. 
There may, in principle, be nothing wrong with housing 
advertising and consumer information under one roof, but to 
allow them to co-mingle is ethically questionable, even if risk 
information per se is presented in a balanced way.  Indeed, it 
raises the issue of accuracy of health information in a new 
and sharper form, and may warrant reassessing accuracy and 
hype in drug advertising in general. Given the often 
uncharted waters of the Internet, with customized and 
intimate conduits for social promotion evolving all the time, it 
appears desirable that educative or informational drug 
content be kept free of trivializing, intimate or factually loose 
language, while urgent investigation is conducted into how 
users are interpreting and responding to the Web and to 
other digital media. 
 
A common-sense divide between promotion and information 
is assumed by FDA, Industry and the consumer, and should be 
possible to maintain. 
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Recommendations 
 
  Regulators and Industry should urgently devise 
Internet-specific guidance for brand drug Web sites. 
  Informational content should be kept distinct from 
promotional content, with particular attention to 
inappropriate style, pervasive images, and 
misleading links or titles. 
  Safety information or a prominent link to it should 
be easily visible without scrolling, for the sake of the 
low-literate. 
  Among other shortcomings to be remedied:  poor 
site organization and navigation, such as duplicate 
and overlapping pages; poor site mapping; lack of 
indication of expert authority. 
  Any new guidance should draw upon linguistics and 
discourse analysis for their holistic insights into the 
workings of Web sites.  
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